[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 14,433,050 shares, a growth of 6.4% [...]
[ad_1] Corindus Vascular Robotics is in the healthcare sector and is in the medical devices industry. The company CEO is Mark J. Toland. Corindus Vascular Robotics Inc is engaged in [...]
[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 14,433,050 shares, a [...]
[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totalling 14,433,050 shares, a [...]
[ad_1] Corindus Vascular Robotics is part of the healthcare sector and is part of the medical devices industry. The company CEO is Mark J. Toland. Corindus Vascular Robotics Inc is [...]
[ad_1] WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that the first clinical robotic-assisted PCI procedures in [...]
[ad_1] WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it filed a registration statement on behalf [...]
[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon bought 10,000 shares of the business’s stock in a transaction on Wednesday, March 27th. The stock was bought at an [...]
[ad_1] Corindus Vascular Robotics is part of the medical devices industry and healthcare sector. The company CEO is Mark J. Toland. Corindus Vascular Robotics Inc is engaged in the design, [...]
[ad_1] Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) Director Louis A. Cannon bought 573,798 shares of the business’s stock in a transaction dated Tuesday, March 12th. The stock was bought at an [...]
